SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2020	Mar. 31, 2019
Segment Net Sales
Total Revenues	$ 354,324	$ 359,690
Segment Profit
Operating income	27,103	32,308
Amortization	(6,977)	(5,279)
Operating Segments
Segment Profit
Operating income	118,506	131,875
Corporate and other
Segment Profit
Operating income	(84,426)	(94,288)
Codman Specialty Surgical
Segment Net Sales
Total Revenues	231,440	234,568
Codman Specialty Surgical \| Operating Segments
Segment Profit
Operating income	87,235	91,380
Orthopedics and Tissue Technologies
Segment Net Sales
Total Revenues	122,884	125,122
Orthopedics and Tissue Technologies \| Operating Segments
Segment Profit
Operating income	$ 31,271	$ 40,495

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Name:	us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration